Abanoquil

Drug Profile

Abanoquil

Alternative Names: UK 52046; UK 5204627

Latest Information Update: 27 Mar 2000

Price : $50

At a glance

  • Originator Pfizer
  • Class Aminoquinolines; Antiarrhythmics; Small molecules; Tetrahydroisoquinolines
  • Mechanism of Action Alpha 1 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Arrhythmias; Ischaemic heart disorders

Most Recent Events

  • 27 Mar 2000 No-Development-Reported for Arrhythmias in United Kingdom (IV-injection)
  • 27 Mar 2000 No-Development-Reported for Arrhythmias in United Kingdom (PO)
  • 27 Mar 2000 No-Development-Reported for Ischaemic heart disorders (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top